03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Phesgo 600mg/600mg : | |
Type | Medicine Authorised |
Originator | Biotech (Phesgo) |
Agent | Omnipharma |
Distributor | Omnipharma |
Laboratory | Roche |
Responsible Party | F. Hoffmann La Roche Ltd |
Origin | Switzerland |
Manufacturer | F. Hoffmann La Roche Ltd, Kaiseraugst |
Origin | Switzerland |
ATC | L01XY02 |
Phesgo 600mg/600mg :
Phesgo 600mg/600mg :
Phesgo 600mg/600mg :
Phesgo 600mg/600mg :
Phesgo 600mg/600mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Phesgo 600mg/600mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Alopecia | Very Common |
Anaemia | Very Common |
Anaphylactic reactions | Uncommon |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Asthenia | Very Common |
Chills | Common |
Congestive heart failure | Uncommon |
Constipation | Very Common |
Cough | Very Common |
Cytokine release syndrome | Rare |
Decreased appetite | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Very Common |
Drug hypersensitivity | Common |
Dry skin | Very Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Very Common |
Dyspnoea (dyspnea) | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Very Common |
Headache | Very Common |
Hot flush | Very Common |
Hypersensitivity | Common |
Infusion related reaction | Very Common |
Injection site reaction | Very Common |
Insomnia | Very Common |
Interstitial lung disease | Uncommon |
Lacrimation increased (Epiphora) | Very Common |
Left ventricular dysfunction | Common |
Leucopenia (Leukopenia) | Very Common |
Mucosal inflammation | Very Common |
Myalgia | Very Common |
Nail disorders | Very Common |
Nasopharyngitis | Very Common |
Nausea | Very Common |
Neuropathy peripheral | Very Common |
Neutropenia | Very Common |
Oedema | Common |
Oedema peripheral | Very Common |
Pain | Common |
Pain in extremity (Pain in limb) | Very Common |
Paraesthesia (paresthesia) | Very Common |
Paronychia | Common |
Peripheral sensory neuropathy | Very Common |
Pleural effusion | Uncommon |
Pruritus | Very Common |
Pyrexia | Very Common |
Skin rash | Very Common |
Stomatitis | Very Common |
Tumour lysis syndrome | Rare |
Upper respiratory tract infection | Common |
Vomiting | Very Common |
Phesgo 600mg/600mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Phesgo 600mg/600mg MoH 11169 :
Form | Solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | 1x10ml |
Strength | 600mg/600mg |
Storage Condition | 2-8°C Protect from light. Do not freeze |
Public Price | 5348082 L.L. |
Stratum | E2 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 118621/1 |
Submission date | 12/10/2021 |
Registration Year | 01/02/2022 |
Price Comparison
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 1x10ml | |
● Public Price: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Pricing Date: | 13/06/2024 |
Note
● Cost/Unit: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Cost/Day: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Cost/Month: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Cost/Unit: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Cost/Day: | 5348082 LBP | ( 5,348,082.00 LBP ) |
● Cost/Month: | 5348082 LBP | ( 5,348,082.00 LBP ) |
You have to register to view this info
Drop File